Sandoz, Holzkirchen (DE)
Ulrich (Ulli) Oßwald, is Head Global BD&L for Sandoz Biopharmaceuticals since June 1, 2013. He is responsible for all biosimilar and biobetter partnering transactions as well as alliance management at Sandoz. Mr. Oßwald works since 2005 on different assignments across different department of the Novartis Group.
Before joining Novartis he gained experience in Corporate Finance + Strategy Consulting at PriceWaterhouseCoopers where he worked for 6 years.
Ulli is a German national, holds a degree in Marketing and Finance (Dipl. Kaufmann) from University Eichstätt/Ingolstadt and a degree from University of Basel (Pharmaceutical Medicine).
He is a Chartered Financial Analyst (EFFAS) and is holder of the CA-AM diploma from the Association of Alliance Management Professionals.